RCAG
APYX icon

Rehmann Capital Advisory Group’s Apyx Medical APYX Stock Holding History

Rehmann Capital Advisory Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$65.1K Hold
9,611
– – 0.01% 552
2019
Q2 		$64.6K Hold
9,611
– – 0.01% 745
2019
Q1 		$60.6K Hold
9,611
– – 0.01% 748
2018
Q4 		$62.3K Hold
9,611
– – 0.01% 522
2018
Q3 		$68.2K Hold
9,611
– – 0.01% 698
2018
Q2 		$41.8K Buy
+9,611
New +$35.5K 0.01% 846

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Rehmann Capital Advisory Group's APYX Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its Apyx Medical (APYX) position steady in Q3 2019 at 9,611 shares worth $65.1K. The position accounts for 0.01% of the portfolio, ranked #552.

Rehmann Capital Advisory Group first reported a position in APYX in Q2 2018 and has held it in 6 quarters since. The position peaked at $68.2K in Q3 2018. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2019.

  • Rehmann Capital Advisory Group held 9,611 shares of Apyx Medical worth $65.1K as of Q3 2019.
  • Rehmann Capital Advisory Group left its Apyx Medical share count unchanged in Q3 2019.
  • Apyx Medical made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #552 holding.
  • Rehmann Capital Advisory Group first reported a position in Apyx Medical in Q2 2018 and has held it in 6 quarters since.
  • Rehmann Capital Advisory Group's Apyx Medical position peaked at $68.2K in Q3 2018.
  • 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.